FDA warns Lifetech Resources on eyelash enhancement claims

04/27/2011 | CosmeticsDesign.com

Marketing campaigns for eyelash cosmetics RapidLash Eyelash Renewal Serum, NeuLash Eyelash Technology and NeuveauBrow Active Eyebrow Technology violate the U.S. Food, Drug, and Cosmetic Act because they contain a drug and claim to make physiological differences which cosmetics are not allowed to do, according to an FDA warning letter.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC